节点文献

关于抗肿瘤药物的研究 Ⅷ.N-甲酰溶肉瘤素酰苯丙氨酸乙酯(FSPA)对动物肿瘤的影响

STUDIES ON ANTITUMOR DRUGS VIII. THE ANTITUMOR EFFECT OF THE ETHYL ESTER OF N-FORMYL-SARCOLYSIN-PHENYLALANINE ON EXPERIMENTAL TUMORS

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 韩锐; 王振纲; 籍秀娟; 刘耕陶; 李广粹; 张慧云; 何适; 范礼理; 雷海鹏;

【Author】 HAN JUEI, WANG CHEN-KANG, CHI HSIU-CH(?)AN, LI KUANG-TSUI, LIU KENG-T’AO, CHANG HUI-YUN, HO SHIH, FAN LI-LI AND LEI HAI-P’ENG (Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking)

【机构】 中国医学科学院药物研究所药理学系; 中国医科大学药理教研室; 中国医学科学院药物研究所药理学系 北京; 北京;

【摘要】 N-甲酰溶肉瘤素酰苯丙氨酸乙酯(FSPA)对动物肿瘤影响的实驗,得到如下的結果:FSPA 100—200毫克/公斤/日能显著的抑制大自鼠吉田腹水肉瘤的生长.FSPA一次腹腔注射,观察二天的LD50为4.5克/公斤.FSPA 100毫克/公斤/日連續14天对猴无明显毒性;200毫克/公斤/日,則对末稍血液中的白血細胞有抑制作用.

【Abstract】 The ethyl ester of N-formyl-sarcolycine-phenylalanine (FSPA) was synthetized in this institute. At a daily dosage of 100-200 mg/kg FSPA markedly inhibited the growth of Yoshida ascites sarcoma. The intraperitoneal LD50 for mice was 4.5 gm/kg. When the drug was administered orally to normal monkeys at 100 mg/kg daily for 14 days, no change in blood picture or impairment of liver and kidney functions was noted. However, at 200 mg/kg FSPA showed definite inhibitory effect on the bone marrow. This compound has been recommended for clinical trial.

  • 【文献出处】 药学学报 ,Acta Pharmaceutica Sinica , 编辑部邮箱 ,1963年08期
  • 【被引频次】3
  • 【下载频次】21
节点文献中: 

本文链接的文献网络图示:

本文的引文网络